November 21, 2024 /

PPMD: 30 Years of Progress

by: Parent Project Muscular Dystrophy

2 years ago

You may also like

Capricor Therapeutics: CAP-1002 HOPE-3 Program Update

Capricor Therapeutics: CAP-1002 HOPE-3 Program Update

3 years ago

Research & Clinical Trial Webinars,

Duchenne Community Advocates to Add Duchenne to Minnesota's Newborn Screening Panel

Duchenne Community Advocates to Add Duchenne to Minnesota’s Newborn Screening Panel

3 years ago

General Information

newborn screening

Edgewise Therapeutics: A Novel Approach Designed to Protect Muscle in Becker Muscular Dystrophy

Edgewise Therapeutics: A Novel Approach Designed to Protect Muscle in Becker Muscular Dystrophy

3 years ago

Research & Clinical Trial Webinars,

Supporting Families Through Decision Making

Supporting Families Through Decision Making

3 years ago

palliative care

Affinity Duchenne™ and Affinity Beyond™: Updates on Investigational RGX-202 from REGENXBIO

Affinity Duchenne™ and Affinity Beyond™: Updates on Investigational RGX-202 from REGENXBIO

3 years ago

Research & Clinical Trial Webinars,

Advocating for Access: Insurance 101

Advocating for Access: Insurance 101

3 years ago

Advocating for Access: Navigating Approved Therapies in Duchenne

Advocating for Access: Navigating Approved Therapies in Duchenne

3 years ago

Research Row Presentation: Viltepso (NS Pharma) - PPMD 2023 Annual Conference

Research Row Presentation: Viltepso (NS Pharma) – PPMD 2023 Annual Conference

3 years ago

2023 PPMD Annual Conference

«1…15 161718 19…68 »

Page 17 of 68

Join Our Mailing List